Baltimore's $80 Million Opioid Settlement with Walgreens: A Step Forward in the Epidemic
Baltimore's Opioid Settlement: Key Highlights
BALTIMORE -- Baltimore City has won $80 million in a settlement with Walgreens, following allegations that the pharmacy chain significantly contributed to the opioid epidemic in the area. The settlement brings the city’s total recoveries from opioid settlements to $402.5 million.
Details of the Settlement
- Baltimore's agreements with CVS and Allergan for $45 million.
- $152.5 million recovered from Cardinal Health.
- $80 million secured from Teva Pharmaceuticals.
Moreover, a case against Johnson & Johnson, McKesson, and AmerisourceBergen is expected to go to trial next week, marking another significant step in addressing the repercussions of the opioid crisis.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.